Lucas Muñoz-Lopez | Neuroscience | Best Academic Researcher Award

Dr. Lucas Muñoz-Lopez | Neuroscience | Best Academic Researcher Award

El Dr. Lucas Muñoz-López 🎓 es logopeda neurológico especializado en rehabilitación logopédica en daño neurológico 🧠, con amplia experiencia clínica y académica 👨‍🏫. Tras graduarse en Logopedia por la Universidad de Granada en 2015, combinó práctica profesional y formación de posgrado, incluyendo dos másteres y un doctorado con mención Cum Laude 🏅. Ha ejercido como docente universitario en Melilla y Ceuta, y colabora en investigación con publicaciones en revistas como Frontiers in Psychology 📖. Además, ha tutorizado numerosos TFG y TFM 🎓. Su trabajo integra logopedia clínica, investigación sobre alteraciones de la comunicación y neurociencias, aportando al avance académico y a la rehabilitación de pacientes. Es autor de un libro publicado y miembro activo en proyectos de evaluación y tratamiento en contextos educativos y sanitarios 🏥. Su pasión por la docencia y la terapia lo posiciona como referente en logopedia clínica e investigación 📈.

Profile

Education 🎓

Dr. Muñoz-López 🧠 inició su carrera académica con el Grado en Logopedia (2015) en la Universidad de Granada 🎓, complementándolo ese mismo año con un Máster en Logopedia Clínica en Daño Cerebral (Isep Clinic, Madrid) 💡. En 2017 completó su segundo máster en Neurociencias Básicas y Aplicadas y Dolor en la Facultad de Medicina de Granada 🔬. Culminó su formación con un Doctorado en Psicología y Logopedia en la Universidad de Granada (2021) con mención Cum Laude 🏅, convirtiéndose en experto en alteraciones de la comunicación y rehabilitación neurológica 🧬. Su formación académica combina sólidos conocimientos clínicos, teóricos y metodológicos para abordar con éxito la intervención logopédica y la investigación científica 🏛️. Además, su trabajo refleja una constante actualización y compromiso con la excelencia educativa y terapéutica 💯.

Experience 👨‍🏫

Desde 2015, el Dr. Muñoz-López 🩺 ha desarrollado una sólida trayectoria profesional como logopeda clínico, combinando práctica asistencial con docencia universitaria 👨‍🏫. Ha ejercido en el Centro de Valoración y Orientación de Granada como Auxiliar Técnico en Logopedia 🏥, además de impartir clases en los campus de Ceuta y Melilla de la Universidad de Granada 📚. Ha sido tutor de TFG y TFM en varias universidades, incluyendo la Universidad de Granada y la Universidad Internacional de La Rioja ✍️. Su experiencia docente abarca asignaturas de logopedia, neuropsicología y psicopedagogía en grados y másteres universitarios 🎓. Además, colabora activamente en proyectos de intervención educativa, rehabilitación y formación de futuros profesionales. Su enfoque multidisciplinar y experiencia en contextos clínicos y penitenciarios 🏛️ le permiten aplicar soluciones eficaces e innovadoras en su área.

Awards & Recognitions 🏅

Dr. Muñoz-López ha recibido mención Cum Laude 🎖️ por su tesis doctoral en Psicología y Logopedia en la Universidad de Granada (2021) 🏅. Su tesis fue publicada como libro 📗, reafirmando su valor académico. Ha logrado publicar en la revista Frontiers in Psychology (Q2, JCR 2.99) 🧠, destacándose en el área de psicología y neurociencias. También ha publicado en la revista Journal for Educators, Teachers and Trainers, indexada en bases relevantes como Scopus y Dialnet 📖. Su libro fue editado por la Editorial Académica Española, con índice ICEE de 0.299 📘. Estos reconocimientos consolidan su reputación científica, reflejando la calidad y relevancia de su producción académica, así como su compromiso con la excelencia investigadora y docente 🧑‍🔬✨.

Research Interests 🔬

El Dr. Muñoz-López centra su investigación en la rehabilitación logopédica de alteraciones de la comunicación 🗣️, disfagia 🥄 y terapia miofuncional 💪, con especial atención a contextos neurológicos y penitenciarios 🏛️. Su trabajo profundiza en la intersección entre neurociencias, psicología y logopedia 🧠, explorando tanto enfoques clínicos como educativos. Ha contribuido al avance del conocimiento en alteraciones del lenguaje, evaluación cognitiva y técnicas de intervención para pacientes con daño cerebral adquirido 🧬. Además, participa en estudios sobre integración social, intervención educativa en contextos de riesgo y psicología forense ⚖️. Su enfoque combina metodología cuantitativa, intervención basada en evidencia y aplicación clínica, orientado siempre a mejorar la calidad de vida de las personas con trastornos de la comunicación 💬💡.

Publications
  • Validation and Spanish Adaptation of the Resilience Scale ER-23 in a University Population

    Healthcare
    2025-04-12 | Journal article
    CONTRIBUTORS: Isabel Ramírez-Uclés; Julia Otero; F. Pablo Holgado-Tello; Lucas Muñoz-López; María B. Sánchez-Barrer
  • Analysis of writing in personality disorders in prison population

    Frontiers in Psychiatry
    2024 | Journal article
    EID:
    Part ofISSN: 16640640
    CONTRIBUTORS: Muñoz-López, L.; Fernández-García-Valdecasas, B.; López-Rodríguez, S.; Sánchez-Barrera, M.B.
  • Transformation of Higher Education: Discussion of the Dimensions, Trends and Scenarios of Change in Ibero-America

    Education Sciences
    2024 | Journal article
    Part ofISSN: 22277102
    CONTRIBUTORS: Fernández Cruz, M.; Fernández García Valdecasas, B.; Muñoz López, L.; López Rodríguez, S
  • Associations of Reversal Learning Performance With Personality Disorder Profile and Drug Abuse History in a Sample of Prison Inmates

    2024-09-18 | Journal article
    CONTRIBUTORS: Raquel Martín-Ríos; José C. Perales; Francisca López-Torrecillas; Lucas Muñoz Lóp

Jolanta Dorszewska | Neurobiology | Women Researcher Award

Dr. Jolanta Dorszewska | Neurobiology | Women Researcher Award

Professor Jolanta Dorszewska is a globally recognized neuroscientist and pharmacologist based at Poznan University of Medical Sciences, Poland 🧠🇵🇱. She leads the Laboratory of Neurobiology, exploring the molecular and genetic basis of neurodegenerative diseases 🧬. With over 35 years of academic experience, her work spans neurochemistry, clinical neurology, and genetic research in Alzheimer’s and Parkinson’s disease 🧪. A prolific author, she has contributed to 80+ research papers, 50+ reviews, and 30+ book chapters 📚. She serves on editorial boards of top neuroscience journals and holds leadership roles in national and international neurological societies 🌍.

Profile

Education 🎓

Prof. Dorszewska earned her M.Sc. in Pharmacy with distinction from Poznan University of Medical Sciences in 1987 🏅. She completed board certifications in Pharmaceutical Analytics (1990 & 1997) and received her Ph.D. in 1996 🧪. In 2004, she qualified as an Associate Professor and achieved full Professorship in 2016 🎓. Her academic growth includes training in medical genetics from 2012 to 2020 🧬. Her education reflects an evolving blend of pharmacy, neurobiology, and genetics, forming the foundation of her current research excellence 💡.

Experience 👨‍🏫

Prof. Dorszewska began as an Assistant in the Dept. of Pharmacy (1987-88), then in Clinical Neurochemistry (1988-96) at PUMS 👩‍🔬. She was a Research Scientist in New York (1999–2000) 🗽 and has led the Laboratory of Neurobiology since 2004 🧠. She became Full Professor in 2022 🏛️. She also lectured at the National High Medical School in Pila (2012–2018) 📖. Her career blends hands-on research, global collaboration, and dedicated academic leadership 📚. She continues to mentor, publish, and drive innovations in neurology and neurochemistry 🚀

Awards & Recognitions 🏅

Awards and Honors:
Prof. Dorszewska is a Local Honorary Member of the 12th World Congress on Controversies in Neurology (2018) 🌐. She has served as Guest Editor for 6 prestigious theme issues and holds editorial roles in top-tier journals like Frontiers in Molecular Neuroscience and Current Alzheimer Research 📘. A section and associate editor for journals across the USA, UK, and Poland 🌍, she’s a key figure in scientific publishing 🖋️. She’s affiliated with the Polish Academy of Sciences and international neurological societies and has co-edited 5 books 📚.

Research Interests 🔬

Research Focus:
Her research spans lipid metabolism in hypoxia 🧫, cerebral sterols 🧠, neurotransmitters (serotonin, dopamine) 🧪, apoptosis in aging and disease (Alzheimer’s, Parkinson’s) 💔, and gene polymorphisms (MTHFR, MAO-B, PARK) 🧬. She investigates homocysteine metabolism, catecholamine pathways, and molecular changes in neurodegeneration 🧠. Since 2009, she’s focused on genetic mutations (PARK, APOE), biomarkers (ASN, microRNAs), and migraine genetics ⚙️. She uses advanced techniques like HPLC, PCR, ELISA, and immunohistochemistry 🔍. Her interdisciplinary work integrates neurobiology, pharmacogenomics, and molecular neuroscience in tackling brain diseases 🚀.

Publications 
  • Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson’s disease

    IBRO Neuroscience Reports
    2025-06 | Journal article
    CONTRIBUTORS: Jolanta Dorszewska; Jolanta Florczak-Wyspiańska; Bartosz Słowikowski; Wojciech Owecki; Oliwia Szymanowicz; Ulyana Goutor; Mateusz Dezor; Paweł P. Jagodziński; Wojciech Kozubski
  • Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis

    Sclerosis
    2025-04-03 | Journal article
    CONTRIBUTORS: Katarzyna Wiszniewska; Małgorzata Wilk; Małgorzata Wiszniewska; Joanna Poszwa; Oliwia Szymanowicz; Wojciech Kozubski; Jolanta Dorszewsk
  • Unraveling the Role of Proteinopathies in Parasitic Infections

    Biomedicines
    2025-03-03 | Journal article
    CONTRIBUTORS: Mikołaj Hurła; Damian Pikor; Natalia Banaszek-Hurła; Alicja Drelichowska; Jolanta Dorszewska; Wojciech Kozubski; Elżbieta Kacprzak; Małgorzata Paul
  • Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine

    International Journal of Molecular Sciences
    2025-02-14 | Journal article
    CONTRIBUTORS: Małgorzata Anna Lewandowska; Agata Różycka; Teresa Grzelak; Bartosz Kempisty; Paweł Piotr Jagodziński; Margarita Lianeri; Jolanta Dorszewska

Tran Chau My Thanh | Neuroscience | Young Scientist Award

Dr. Tran Chau My Thanh | Neuroscience | Young Scientist Award

Dr. Tran Chau My Thanh, a dedicated researcher at Duy Tan University, Vietnam 🇻🇳, holds a medical degree and Ph.D. from Hue University of Medicine and Pharmacy 🎓. Her work bridges the gap between clinical medicine and molecular biology 🧬. With a strong passion for translational research, she focuses on using bioinformatics and genomic tools for early diagnosis and targeted therapy development for diseases like cancer, diabetes, and cardiovascular disorders 💉. Through CRISPR/Cas9 and RNA networks, she aims to revolutionize patient-specific treatment pathways 🚀. Her extensive lab experience, scholarly publications, and ongoing innovations make her a promising leader in biomedical science 🏅.

Profile

Education 🎓

Dr. Thanh earned her Medical Degree (M.D.) from Hue University of Medicine and Pharmacy 🏥 and went on to complete her Doctorate (Ph.D.) in the same prestigious institution 🎓. Her education was deeply rooted in both clinical and research training, equipping her with a comprehensive understanding of human health and disease 🧠. Throughout her academic journey, she focused on genomics, molecular medicine, and biotechnology 🔬. The rigorous curriculum and hands-on exposure in advanced labs trained her in modern diagnostic tools and therapeutic innovations ⚙️. She also mastered computational biology and molecular interactions, forming a solid foundation for her groundbreaking work in RNA regulation and gene editing technologies such as CRISPR/Cas9 🧪.

Experience 👨‍🏫

Dr. Thanh brings rich experience as a medical doctor and academic at Duy Tan University 🏫. Her research career spans multiple roles in molecular diagnostics, bioinformatics, and therapeutic innovation 🧬. She has led studies on disease biomarkers, participated in international collaborations 🌐, and worked extensively with cell lines, recombinant DNA, and next-gen sequencing data 🔍. Her proficiency in wet lab and dry lab environments empowers her to integrate experimental biology with computational modeling 🧫💻. Alongside mentoring students and publishing SCI-indexed research, she contributes to translational medicine by connecting bench science to bedside applications, helping advance precision medicine for critical illnesses 💡.

Awards & Recognitions 🏅

Dr. Thanh is a nominee for the Young Scientist Award by the International Cognitive Scientist Awards 🧠🏆. Her impactful work on circular RNAs, miRNAs, and disease biomarker networks has garnered international recognition 🌍. She’s been acknowledged in high-impact journals for discoveries related to coronary heart disease and cancer diagnostics 📖. Her scholarly articles are indexed in SCI and Scopus, and she continues to influence the biomedical community through conference presentations, peer reviews, and academic collaborations 🤝. As a rising figure in molecular biology, her research promises transformative outcomes for early disease detection and targeted therapies 🧬✨.

Research Interests 🔬

Dr. Thanh’s research explores circRNA/miRNA/mRNA interactions, protein-protein networks, and gene function analysis 🧬🧠. She is driven by the quest to discover novel biomarkers for early diagnosis of complex diseases such as cancer, stroke, and diabetes 💊. Her focus includes CRISPR/Cas9 gene editing, molecular docking, and simulations for drug discovery and target validation 💻🧪. She also builds interaction networks to map LncRNA/CircRNA/miRNA/gene/protein-drug relationships, contributing to personalized medicine approaches 🎯. Through bioinformatics, she decodes gene expression dynamics and immune infiltrations to enable efficient diagnostics and therapeutics 💡. Her ultimate goal is to bridge computational biology with translational research for global health improvement 🌐💚.

Publications 

1. Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression
by sponging miRNA-338-3p via regulating the expression of ETS1
2. Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as
potential biomarker for coronary heart disease
3. Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of
bioinformatics data

Elsa Pittaras | Neuroscience | Women Researcher Award

Dr. Elsa Pittaras | Neuroscience | Women Researcher Award

Elsa Pittaras is a Basic Life Research Scientist at Stanford University, specializing in neuroscience, cognition, and sleep research. With expertise in molecular biology, neuroanatomy, pharmacology, and behavior, she has extensively studied decision-making processes in mice. Her research has contributed significantly to understanding sleep deprivation’s effects on cognition and memory in Down Syndrome and Alzheimer’s disease models. She has published multiple papers as both first and last author, showcasing her leadership in neuroscience. Elsa’s goal is to advance research on mood disorders, cognition, and neurochemistry, aspiring to become an independent researcher in the U.S. 🇺🇸🔬🧠

Profile

Education 🎓

Elsa Pittaras earned a B.S. in Physiology from the University of Caen (2010), an M.S. in Neuroscience from the University of Paris Sud and ENS Cachan (2012), and a Ph.D. in Neuroscience from Neuro-PSI and the Biomedical Research Unit of the French Army (2016). Her multidisciplinary foundation in biology, physics, chemistry, and mathematics from Châtelet, Douai (2009) laid the groundwork for her neuroscience expertise. Throughout her education, she focused on decision-making, sleep deprivation, and neurochemical mechanisms in cognition. 🧠📚🎓

Experience 👨‍🏫

Elsa Pittaras has been a Basic Life Research Scientist at Stanford University since 2022, focusing on cognitive enhancement in Down Syndrome and Alzheimer’s disease models. She was a Postdoctoral Fellow at Stanford (2017-2022), investigating sleep and circadian rhythms’ effects on memory. Previously, she conducted research at the Biomedical Research Unit of the French Army (2016-2017) and completed her Ph.D. at Neuro-PSI. Her career includes internships in neuroscience at Neuro-PSI (2011-2012) and clinical observations at CHU Caen (2010). 🏛️🧬🧪

Research Interests 🔬

Elsa’s research explores decision-making, memory, and sleep in neurodevelopmental disorders. She pioneered the Mouse Gambling Task, revealing individual decision-making strategies. Her Ph.D. identified neurochemical markers of decision-making behaviors and the effects of sleep deprivation. At Stanford, she investigates sleep’s impact on cognition in Down Syndrome and Alzheimer’s models, aiming to improve memory and sleep quality through pharmacological interventions. Her work bridges behavioral neuroscience with neurochemistry to enhance cognitive function. 🧠💡🛌

Awards & Recognitions 🏅

Elsa has received prestigious grants, including the Jerome Lejeune Research Grants (2019, 2020), the Fyssen Foundation Research Grant (2017), and travel awards for conferences such as T21RS (2021) and Advances in Sleep and Circadian Science (2019). She was also recognized by the French Society for Research and Sleep Medicine (2014) and received a European Neuroscience Federation travel award (2016). 🏅

Publications 

  • Selectively Blocking Small Conductance Ca2+-Activated K+ Channels Improves Cognition in Aged Mice.

  • Short-term γ-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model

  • Behavioral and Neuronal Characterizations, across Ages, of the TgSwDI Mouse Model of Alzheimer’s Disease.

  • Inter-individual differences in cognitive tasks: focusing on the shaping of decision-making strategies

  • Handling, task complexity, time-of-day, and sleep deprivation as dynamic modulators of recognition memory in mice

  • Enhancing sleep after training improves memory in down syndrome model mice